Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Neural Transmission (Vienna, Austria : 1996)|August 31, 2025
Opicapone in Parkinson's disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefitClelia Pellicano, Daniele Belvisi, Roberta Bovenzi, et al.
Movement Disorders Clinical Practice|December 20, 2024
Gastrointestinal Dysfunction Bears on the Clinical-Biological Profile of Parkinson's DiseaseJacopo Bissacco, Roberta Bovenzi, Matteo Conti, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 20, 2023
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical CorrelatesMatteo Conti, Andrea Guerra, Mariangela Pierantozzi, et al.
Journal of Neurology|March 16, 2024
A biological characterization of patients with postmenopausal Parkinson's diseaseRoberta Bovenzi, Tommaso Schirinzi, Matteo Conti, et al.
Parkinsonism & Related Disorders|June 8, 2023
Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patientsPiergiorgio Grillo, Giulia Maria Sancesario, Roberta Bovenzi, et al.
Neurobiology of Aging|July 9, 2025
Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson's disease patients independently of APOEDavide Mascioli, Matteo Conti, Jacopo Bissacco, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 16, 2024
Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear PalsyMarco Rosina, Federica Veltri, Valentina Nesci, et al.
Brain, Behavior, and Immunity|December 22, 2022
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunctionTommaso Schirinzi, Roberta Lattanzi, Daniela Maftei, et al.
Journal of Neurology|August 13, 2025
CSF phospho-tau levels at Parkinson's disease onset predict the risk for development of motor complicationsJacopo Bissacco, Giulia Di Lazzaro, Roberta Bovenzi, et al.
Molecular Neurobiology|April 3, 2024
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory PathwayTommaso Schirinzi, Daniela Maftei, Riccardo Maurizi, et al.
Pageof 5